Corvus Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JACKSON SQUARE CAPITAL, LLC | 10/09/2025 | 63.77 K | $470.01 K | 0.00% | 0.08% |
| HIKARI POWER LTD | 10/22/2025 | 49.96 K | $368.00 K | 0.00% | 0.06% |
| TEMA ETFS LLC | 10/24/2025 | 59.20 K | $436.32 K | 100.00% | 0.08% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 126.53 K | $932.51 K | 14.31% | 0.16% |
| TOWERVIEW LLC | 11/04/2025 | 170.00 K | $1.25 M | 0.00% | 0.22% |
| RHUMBLINE ADVISERS | 11/06/2025 | 82.59 K | $608.68 K | 8.74% | 0.11% |
| VANGUARD GROUP INC | 11/07/2025 | 3.47 M | $25.59 M | 5.83% | 4.46% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 401.41 K | $2.96 M | 25.94% | 0.52% |
| NEOS INVESTMENT MANAGEMENT LLC | 11/07/2025 | 59.20 K | $436.32 K | 100.00% | 0.08% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 177.79 K | $1.31 M | 9.87% | 0.23% |
| EMPIRICAL FINANCIAL SERVICES, LLC D.B.A. EMPIRICAL WEALTH MANAGEMENT | 11/10/2025 | 169.20 K | $1.25 M | 0.71% | 0.22% |
| BLACKROCK, INC. | 11/12/2025 | 4.71 M | $34.72 M | 11.14% | 6.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.46 M | $10.74 M | 6.96% | 1.87% |
| BARCLAYS PLC | 11/12/2025 | 309.15 K | $2.28 M | -10.01% | 0.40% |
| NUVEEN, LLC | 11/12/2025 | 68.06 K | $501.63 K | 0.00% | 0.09% |
| UBS GROUP AG | 11/13/2025 | 162.07 K | $1.19 M | 80.66% | 0.21% |
| HSBC HOLDINGS PLC | 11/13/2025 | 82.39 K | $586.60 K | -2.24% | 0.11% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 53.64 K | $395.32 K | 21.94% | 0.07% |
| INVESCO LTD. | 11/13/2025 | 38.67 K | $285.02 K | -4.76% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 36.40 K | $268.23 K | 34.45% | 0.05% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 33.59 K | $247.59 K | 4.68% | 0.04% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 7.17 M | $52.81 M | 0.00% | 9.21% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 6.45 M | $47.57 M | -8.35% | 8.30% |
| ADAMS STREET PARTNERS LLC | 11/14/2025 | 3.28 M | $24.14 M | 0.00% | 4.21% |
| RTW INVESTMENTS, LP | 11/14/2025 | 2.68 M | $19.75 M | 0.00% | 3.45% |
| VIVO CAPITAL, LLC | 11/14/2025 | 2.23 M | $16.47 M | 0.00% | 2.87% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 11/14/2025 | 1.73 M | $12.76 M | 0.00% | 2.23% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.44 M | $10.60 M | 0.00% | 1.85% |
| STATE STREET CORP | 11/14/2025 | 1.01 M | $7.42 M | 51.38% | 1.29% |
| MORGAN STANLEY | 11/14/2025 | 617.22 K | $4.55 M | -30.99% | 0.79% |
| NORTHERN TRUST CORP | 11/14/2025 | 466.49 K | $3.44 M | 15.71% | 0.60% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 445.67 K | $3.28 M | 161.83% | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 407.71 K | $3.00 M | 122.68% | 0.52% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 203.36 K | $1.50 M | -9.18% | 0.26% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 180.18 K | $1.33 M | 76.04% | 0.23% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 161.60 K | $1.19 M | -24.02% | 0.21% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 151.97 K | $1.12 M | 14.49% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 149.90 K | $1.10 M | 251.88% | 0.19% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 124.50 K | $917.54 K | 0.00% | 0.16% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 96.44 K | $710.76 K | 100.00% | 0.12% |
| JANE STREET GROUP, LLC | 11/14/2025 | 68.07 K | $501.65 K | 572.72% | 0.09% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 67.99 K | $390.28 K | 1.00% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2025 | 66.80 K | $492.32 K | 74.87% | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 66.70 K | $491.58 K | 0.00% | 0.09% |
| ROYAL BANK OF CANADA | 11/14/2025 | 60.84 K | $448.00 K | -47.07% | 0.08% |
| DIADEMA PARTNERS LP | 11/14/2025 | 50.00 K | $368.50 K | 100.00% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2025 | 48.20 K | $355.23 K | 18.14% | 0.06% |
| ANCORA ADVISORS, LLC | 11/14/2025 | 47.29 K | $348.53 K | 9.70% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 44.10 K | $325.02 K | 60.95% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2025 | 42.77 K | $315.19 K | 100.00% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Corvus Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 135 institutional investors and hedge funds held shares of Corvus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 7.17 M
Point72 Asset Management, L.P.: 6.45 M
BlackRock, Inc.: 4.71 M
VANGUARD GROUP INC: 3.47 M
ADAMS STREET PARTNERS LLC: 3.28 M
RTW INVESTMENTS, LP: 2.68 M
53.58% of Corvus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 44.45 M shares in the last 24 months. This purchase volume represents approximately $391.59 M in transactions.